morning, everyone, your in for interest and you thank Good Avanos. Dave. Thanks,
I'm pandemic COVID-XX the of demonstrated of As the global with needs by products. up to proud and clear together, of meet urgent the we patients critical our our has confront made team The resilience stepping healthcare. importance
to was on system reduce pneumonia when the Health suction assisted Organization World patients deliver solutions suspected. to for most on, Early a incidence improve ventilated medical closed the mission clinically Our device ventilator to proves published proven today. quality COVID-XX of of relevant life mechanically using help guidelines
nasogastric helps outside and used as COVID-XX caregiver. CORTRAK the nutrition. the also therapy providing patients maintains only of cross-contamination to of early ventilation placement exposure suctioning WHO tubes being to system oxygen pathogen market-leading Our suction risk Ballard is the procedure, confirmation also but patient closed and recommends throughout the in Further, reduce not and
expand provide that respiratory result accelerating Additionally, care the we're of help as of a future. can exploration in and this innovations the pandemic, global
we're Medicine instance, to currently a the in at Niklason treating partnering to the of role on Avanos, that for and vision getting School at be Dr. evaluate of her respiratory to Across with solutions being patients team executing University matter. our best and pleased leadership patients. things For novel we're patients playing the back Yale COVID-XX ventilated
pandemic, and As we strong of of support and face respiratory financial return. safety we in the families; focused sufficient our three position our of elected employees positioned used their the have maintaining third, and challenges priorities; when preserving are well the customers first, procedures health on we ensuring products COVID-XX and patients; our ensuring we supply treating to second, health remain
remotely across answer priority Board this of and updates navigating our leadership the with safety remain virus. minimize protect resources, At almost Directors. teams. Medical to working be them nonmanufacturing to employees the employees. employees While to our have and challenging been connected mid-March, the been exposure with our communications their provide challenge and This Since we hasn't continues but environment, through frequent top COVID-XX. health easy, our with measures implemented sessions our providing of daily to their are I the the senior to questions team organization our The Officer including information Chief frequent onset, meet and team precautionary leadership about to our
environment. China. challenges third manufacturing the availability our employees party which early pandemic the products global quarter rigorous safe and is working which to The managing on placed nature The a our of manufactured our we've work organization additional is of to to infected. in critical treat NeoMed, of the inventory in us ensure in those instituted for a facilities, protect safety operate, At to precautions manufacturing to ensure continue our by
environment, to us remained our products implemented they've the resilience I'm anticipated demonstrated customers, and digit. and the while grow The to Avanos employees dynamic dedication the by strength testament have the demonstrated Across a available of the responsibilities our this employees double new team. mitigation plan, challenges our standards. team executing ensuring for to adapting rising what is in Our facing proud enabling to work a and risk organization, highest new our of to the business the of their
purchase Also, donated much our with involvement, of to doing of $XXX,XXX thank for workers who so to community all And we want direct the of we keeping are healthcare frontline culture relief for us. the PPE.
donation. a are supporting employees our can program in charities to local frontline whereby directly cash nominate initiated we who Additionally, communities receive workers our
to proven our respiratory Moving clinically available second patients We're our suffering remain health and products priority. customers to ensuring COVID-XX. from
we pandemic our core business the this supply disruption for our an of in products. on demand, increased In spreads, respiratory continuity As increase and of employees. production anticipation minimize executed chain to ensuring we plans safety health our demand and the while and saw health
feeding Health We supply who We're in ensure of added tubes. ways help a operating clinically for customers COVID-XX our Digestive suction preferred time available patients. training CORTRACK using essential team hoarding found are back minimize shifts products to process need Moreover, has and are of this allocation our we to seven week, treating is ensure Magdalena closed place and of implemented and formed products innovative proud prevent our they during deliver Digestive to portfolio virtual patients. caregivers is orders. Respiratory Health for plant, XX to receive days which cross-functional the catheters now an to Meanwhile, hours, teams to our
a steps priority. our strategic so post-COVID-XX meeting third financial to solid to taking position Moving that preserve needs continue on our we can environment. focusing We're customers' in
expenditures, taking allow cash to disruption other preserve requiring by market existing our We're capital without that spending to discretionary cash disciplined our planned global us strategically reducing cutting our resources. suspending our liquidity confident merit steps position the navigate increases. will and are We XXXX
the to cost use and will operating Michael of details Security net provide These million we measures. Relief, announced provisions to Economic cash previously enhance Aid, the relief specific Act Coronavirus delivering million the $XX Also, coming or flow quarters. in plan to steps the addition to additional mitigation Act in actions. about provided are carrybacks CARES loss over our our our savings $XX to tax
the current the near-term remain of environment challenges, long-term our Although strong. business presents fundamentals
leadership us attractive preserve have We market. in solid with strategic financial instituting to to combined position the cash, position, market meet customers' These factors, portfolio post-COVID-XX across our we're in and a actions environment. operate needs a
plans let's Sales first Respiratory tailwind per March. catheters suction saw $XXX with in delivered mid-March result. Health we COVID-XX quarter We in from adjusted diluted products. to line were Now closed our of turn our and earnings related impacted and franchises Sales million $X.XX half were orders our totaled when of share. a of until by second the broadly increased
and and momentum the year. of franchise. the volumes compared impacted This Offsetting was has our second the quarter prior procedures of of continued the this which the to second electric with year. year, significantly continue postponement believe ON-Q lesser quarter pain second headwind into We extent, into this to this will down COOLIEF management the a impact into half
environment continued time, the our Given scope pandemic we the of the the this on impact of XXXX results. quantify of duration full guidance. cannot rapidly surrounding evolving and the At financial uncertainty the financial year we withdrawing previously fully and COVID-XX, impact announced our are
detailed more providing later updates anticipate we this However, year.
remain progress our and the strategy of focused we mind, long-term pandemic XXXX continuing our Although top on priorities. on is
by Our evidence of to pain. COOLIEF RF knee the favorably The introduction COOLIEF quarter, of and to the launch momentum. future article art generator our use new the treatment the an published new first of demonstrating our COOLIEF, XX-Watt state priority the clinical drive OA demonstrates robust with opinion of is of during reviews clinical that is a in growth. Also literature generator, efficacy recent coupled that been to our build supports of our expected The increasing the key innovation. received physicians has sales commitment leader
Second, integration. of procedures. integrating the Summit we Ready, in and acquisitions expect the from and growth quarter, NeoMed's the the Game expectations them our for remain elective gain impacted mostly quarter to end from the NeoMed decline exceeded on Game while post Summit sales in and Ready to synergies were at continue track
generating Third, for free on current longer given the environment impact flow cash year. anticipate positive we our business, and the no
as However, position and help outflow. implementing our the strong maintain Act and we the us opportunities mitigation to in are I minimize cash actions liquidity use earlier, mentioned CARES planning to
progress the realize of its stabilization new our system to and IT continue efficiencies. we Finally,
the enter pandemic, half of we year us. behind the challenges to second expected IT Before the with our
continue goal. position to given to of to post a strategic position with the coupled fundamentals maintain long-term our COVID-XX actions cash financial focus work year. to our strong summary, current that challenges remain committed this weather and taking strong. we remain now the and But a the storm In and that preserve of prudent environment. environment restrictions, few This in us we're confident we the a these with remain manage We second into half travel to work areas expect continue
the call to over turn Michael. I'll Now